Effects of Thoracic Epidural Analgesia in Geriatric Patients Undergoing Open Heart Surgery
Effect of Thoracic Epidural Analgesia on Short-term Outcome and Mortality in Geriatric Patients With Open Heart Surgery
1 other identifier
observational
640
1 country
1
Brief Summary
Elderly patients have a higher incidence of morbidity and mortality due to the interaction of various factors such as decreased physiological reserves, concomitant comorbidities, multiple drug use, cognitive dysfunction, and frailty. Surgical stress, pain and associated lung complications are common problems in open heart surgeries that can affect morbidity and mortality. With a good postoperative pain control and improved respiratory mechanics, complications that may develop in patients can be significantly prevented, and the hospital cost can be reduced and the workforce loss of patients can be reduced by reducing the length of hospital stay in the intensive care unit. Thoracic epidural analgesia (TEA) is an anesthetic analgesia method that has positive effects on many organ systems as well as providing good pain control and is frequently used in open heart surgery. The aim of this study is to investigate the effects of TEA on postoperative respiratory mechanics in geriatric patients, based on analgesia levels, extubation times, length of stay in intensive care, arterial blood gases, morbidity and mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 8, 2021
CompletedFirst Posted
Study publicly available on registry
January 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2021
CompletedMarch 2, 2021
February 1, 2021
7 months
January 8, 2021
February 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
the effect of thoracic epidural analgesia
postoperative respiratory parameters
up to 4 weeks
the effect of thoracic epidural analgesia
Patients' sedation and analgesia levels
postoperative period 3 day
the effect of thoracic epidural analgesia
extubation times
1 day
the effect of thoracic epidural analgesia
postoperative respiratory complications
1 month
the effect of thoracic epidural analgesia
lengths of ICU and hospitality stay
up to 4 weeks
the effect of thoracic epidural analgesia
mortality
1 year
Study Arms (2)
Group E
patients who underwent thoracic epidural catheter for postoperative analgesia
Group I
Patients who cannot be applied thoracic epidural catheter for postoperative analgesia
Interventions
A thoracic epidural catheter is routinely placed in patients undergoing open heart surgery in our hospital, at least 1 hour before heparin administration during the operation. After standard monitoring (ECG, SpO2, NIBP) is applied to the patients in the operating room, sedoanalgesia is provided with 1-3mg of midazolam and 50-100mcg of fentanyl. Then, by providing sterilization conditions, an epidural catheter is inserted through the T5-T6 interval with Tuohy needle. After confirming the location of the epidural catheter, 25mg / 10ml bupivacaine is administered as a bolus and then 3ml / hour bupivacaine infusion is started from the solution prepared as 3mg / ml and continues until the 48th postoperative hour. On the postoperative 2nd day, the catheter is removed 10-12 hours after LMWH administration and 2-4 hours after UFH, as recommended by the guidelines, paying attention to the anticoagulant administration times applied to the patients.
Eligibility Criteria
This study was planned as a retrospective (retrospective) study involving patients aged 65 and over who underwent elective open heart surgery between January 1, 2008 and December 31, 2019.
You may qualify if:
- Elective patients undergoing open heart surgery
You may not qualify if:
- Emergency operations
- Patients whose data cannot be reached
- Patients younger than 65
- Patients whose records could not be accessed and who were excluded from the study group procedure in which they were included for any reason will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karadeniz Technical University
Trabzon, 61080, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
January 8, 2021
First Posted
January 13, 2021
Study Start
July 1, 2020
Primary Completion
February 1, 2021
Study Completion
February 15, 2021
Last Updated
March 2, 2021
Record last verified: 2021-02